Antioxidants as potential therapeutics for neuropsychiatric disorders

Chirayukumar D Pandya, Kristy R. Howell, Anilkumar R Pillai

Research output: Contribution to journalReview article

90 Citations (Scopus)

Abstract

Oxidative stress has been implicated in the pathophysiology of many neuropsychiatric disorders such as schizophrenia, bipolar disorder, major depression etc. Both genetic and non-genetic factors have been found to cause increased cellular levels of reactive oxygen species beyond the capacity of antioxidant defense mechanism in patients of psychiatric disorders. These factors trigger oxidative cellular damage to lipids, proteins and DNA, leading to abnormal neural growth and differentiation. Therefore, novel therapeutic strategies such as supplementation with antioxidants can be effective for long-term treatment management of neuropsychiatric disorders. The use of antioxidants and PUFAs as supplements in the treatment of neuropsychiatric disorders has provided some promising results. At the same time, one should be cautious with the use of antioxidants since excessive antioxidants could dangerously interfere with some of the protective functions of reactive oxygen species. The present article will give an overview of the potential strategies and outcomes of using antioxidants as therapeutics in psychiatric disorders.

Original languageEnglish (US)
Pages (from-to)214-223
Number of pages10
JournalProgress in Neuro-Psychopharmacology and Biological Psychiatry
Volume46
DOIs
StatePublished - Oct 1 2013

Fingerprint

Antioxidants
Psychiatry
Reactive Oxygen Species
Therapeutics
Defense Mechanisms
Bipolar Disorder
Schizophrenia
Oxidative Stress
Depression
Lipids
DNA
Growth
Proteins

Keywords

  • Antioxidant
  • Neuropsychiatric disorders
  • Oxidative stress

ASJC Scopus subject areas

  • Pharmacology
  • Biological Psychiatry

Cite this

Antioxidants as potential therapeutics for neuropsychiatric disorders. / Pandya, Chirayukumar D; Howell, Kristy R.; Pillai, Anilkumar R.

In: Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 46, 01.10.2013, p. 214-223.

Research output: Contribution to journalReview article

@article{678e920d16324a22a5b124a5a3b09fd0,
title = "Antioxidants as potential therapeutics for neuropsychiatric disorders",
abstract = "Oxidative stress has been implicated in the pathophysiology of many neuropsychiatric disorders such as schizophrenia, bipolar disorder, major depression etc. Both genetic and non-genetic factors have been found to cause increased cellular levels of reactive oxygen species beyond the capacity of antioxidant defense mechanism in patients of psychiatric disorders. These factors trigger oxidative cellular damage to lipids, proteins and DNA, leading to abnormal neural growth and differentiation. Therefore, novel therapeutic strategies such as supplementation with antioxidants can be effective for long-term treatment management of neuropsychiatric disorders. The use of antioxidants and PUFAs as supplements in the treatment of neuropsychiatric disorders has provided some promising results. At the same time, one should be cautious with the use of antioxidants since excessive antioxidants could dangerously interfere with some of the protective functions of reactive oxygen species. The present article will give an overview of the potential strategies and outcomes of using antioxidants as therapeutics in psychiatric disorders.",
keywords = "Antioxidant, Neuropsychiatric disorders, Oxidative stress",
author = "Pandya, {Chirayukumar D} and Howell, {Kristy R.} and Pillai, {Anilkumar R}",
year = "2013",
month = "10",
day = "1",
doi = "10.1016/j.pnpbp.2012.10.017",
language = "English (US)",
volume = "46",
pages = "214--223",
journal = "Progress in Neuro-Psychopharmacology and Biological Psychiatry",
issn = "0278-5846",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Antioxidants as potential therapeutics for neuropsychiatric disorders

AU - Pandya, Chirayukumar D

AU - Howell, Kristy R.

AU - Pillai, Anilkumar R

PY - 2013/10/1

Y1 - 2013/10/1

N2 - Oxidative stress has been implicated in the pathophysiology of many neuropsychiatric disorders such as schizophrenia, bipolar disorder, major depression etc. Both genetic and non-genetic factors have been found to cause increased cellular levels of reactive oxygen species beyond the capacity of antioxidant defense mechanism in patients of psychiatric disorders. These factors trigger oxidative cellular damage to lipids, proteins and DNA, leading to abnormal neural growth and differentiation. Therefore, novel therapeutic strategies such as supplementation with antioxidants can be effective for long-term treatment management of neuropsychiatric disorders. The use of antioxidants and PUFAs as supplements in the treatment of neuropsychiatric disorders has provided some promising results. At the same time, one should be cautious with the use of antioxidants since excessive antioxidants could dangerously interfere with some of the protective functions of reactive oxygen species. The present article will give an overview of the potential strategies and outcomes of using antioxidants as therapeutics in psychiatric disorders.

AB - Oxidative stress has been implicated in the pathophysiology of many neuropsychiatric disorders such as schizophrenia, bipolar disorder, major depression etc. Both genetic and non-genetic factors have been found to cause increased cellular levels of reactive oxygen species beyond the capacity of antioxidant defense mechanism in patients of psychiatric disorders. These factors trigger oxidative cellular damage to lipids, proteins and DNA, leading to abnormal neural growth and differentiation. Therefore, novel therapeutic strategies such as supplementation with antioxidants can be effective for long-term treatment management of neuropsychiatric disorders. The use of antioxidants and PUFAs as supplements in the treatment of neuropsychiatric disorders has provided some promising results. At the same time, one should be cautious with the use of antioxidants since excessive antioxidants could dangerously interfere with some of the protective functions of reactive oxygen species. The present article will give an overview of the potential strategies and outcomes of using antioxidants as therapeutics in psychiatric disorders.

KW - Antioxidant

KW - Neuropsychiatric disorders

KW - Oxidative stress

UR - http://www.scopus.com/inward/record.url?scp=84883558764&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883558764&partnerID=8YFLogxK

U2 - 10.1016/j.pnpbp.2012.10.017

DO - 10.1016/j.pnpbp.2012.10.017

M3 - Review article

VL - 46

SP - 214

EP - 223

JO - Progress in Neuro-Psychopharmacology and Biological Psychiatry

JF - Progress in Neuro-Psychopharmacology and Biological Psychiatry

SN - 0278-5846

ER -